Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Prolactin-Producing Pituitary Tumor 1 Pituitary ACTH Hypersecretion 1 Neoplasm Metastasis 1 Metastatic Solid Tumor Cancers 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Depression 1 Cushing Syndrome 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Caregivers 1

Interventions

Oxaliplatin 27 Fluorouracil 23 Leucovorin 22 Cetuximab 22 Bevacizumab 21 Nivolumab 16 Capecitabine 16 Irinotecan 15 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Specimen Handling 10 encorafenib 8 Folfox protocol 7 trifluridine tipiracil drug combination 6 Ipilimumab 6 Exercise 6 fludarabine 5 cemiplimab 5 Trastuzumab 5 Gemcitabine 5 Cyclophosphamide 5 Cisplatin 5 Blood Specimen Collection 5 Biopsy 5 regorafenib 4 pertuzumab 4 adagrasib 4 Trifluridine 4 Pemetrexed 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × 4-amino-4'-hydroxylaminodiphenylsulfone × 1 year × Clear all

NCT05934643 2025-07-16

PHYSPAL

University of Nottingham

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡